Mass General Brigham Launches Genetic Test for Eight Cardiovascular Conditions
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH's All of Us Research Program.
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH's All of Us Research Program.
Genomill's Bridge Capture technology achieved gold-standard sensitivity in detecting mutations in metastatic colorectal cancer patients.
Bruker announced major advancements at ESCMID Global, including expanded PCR assay options for its BeGenius system.
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read MoreOGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read MoreWhile serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.Â
Read MoreTwo studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
Read MoreDelve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read MoreA mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read MoreA study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
Read MoreBiotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read MoreIllumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read MoreReducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read MoreThe next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MoreA new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Read MoreAmbry Genetics unveiled a new multiomic exome sequencing test that incorporates RNA analysis to enhance the detection of rare diseases.
Read MoreGeneDx announced enhancements to its whole genome sequencing services, all aimed at accelerating diagnoses and improving health outcomes.
Read MoreBaylor Genetics and Baylor College of Medicine have launched the Medical Genetics Multi-Omics Laboratory to innovate genetic testing.
Read More